[1]
Gonakoti, S. and Parra-Rodriguez, L. 2021. Should CD4 Levels be Monitored in a Patient on Temozolomide?. European Journal of Case Reports in Internal Medicine. 8, 3 (Mar. 2021). DOI:https://doi.org/10.12890/2021_002276.